Biotechnology Letters
eISSN: 1573-6776pISSN: 0141-5492
Share this on:
Key Metrics
CiteScore 
4
SJR
Q3Biotechnology
Topics Covered
Glycerol
Escherichia coli
Bacillus subtilis
Lipase
Lipid accumulation
Flow cytometry
Lupinus mutabilis
Aspergillus niger
Thermal stability
Chitosan
Continuous production
Mutant
Mitochondrial abnormalities
Nitrilase
Fusion protein
Transcriptome
Municipal solid waste
Fusarium solani
Lipopeptide
Substrate specificity
Journal Specifications
Indexed in the following public directories
Scopus 
Web of Science
Overview
- PublisherSpringer Nature
- LanguageEnglish
- FrequencyMonthly
- Article Processing ChargesUSD 3280
General Details
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1979
- Publisher URL
Publication Details
View less
Planning to publish in Biotechnology Letters ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers
Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer
- 18 Jan 2023
- Biotechnology Letters
Establishment of a visual gene knockout system based on CRISPR/Cas9 for the rare actinomycete Nonomuraea gerenzanensis
- 18 Jan 2023
- Biotechnology Letters
Establishment and characterization of immortalized human vocal fold fibroblast cell lines
- 18 Jan 2023
- Biotechnology Letters
Retraction Note: miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1
- 10 Jan 2023
- Biotechnology Letters
Cellulase and chitinase activities and antagonism against Fusarium oxysporum f.sp. cubense race 1 of six Trichoderma strains isolated from Mexican maize cropping
- 6 Jan 2023
- Biotechnology Letters
Functional characterization of glycine oxidase from Bacillus licheniformis in Escherichia coli and transgenic plants
- 2 Jan 2023
- Biotechnology Letters
Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer
- 18 Jan 2023
- Biotechnology Letters
Establishment of a visual gene knockout system based on CRISPR/Cas9 for the rare actinomycete Nonomuraea gerenzanensis
- 18 Jan 2023
- Biotechnology Letters
Establishment and characterization of immortalized human vocal fold fibroblast cell lines
- 18 Jan 2023
- Biotechnology Letters
Retraction Note: miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1
- 10 Jan 2023
- Biotechnology Letters
Cellulase and chitinase activities and antagonism against Fusarium oxysporum f.sp. cubense race 1 of six Trichoderma strains isolated from Mexican maize cropping
- 6 Jan 2023
- Biotechnology Letters
Functional characterization of glycine oxidase from Bacillus licheniformis in Escherichia coli and transgenic plants
- 2 Jan 2023
- Biotechnology Letters
FAQs
How long has Biotechnology Letters been actively publishing? 
Biotechnology Letters has been in operation since 1979 till date.
What is the publishing frequency of Biotechnology Letters?
Biotechnology Letters published with a Monthly frequency.
How many articles did Biotechnology Letters publish last year?
In 2022, Biotechnology Letters publsihed 125 articles.
What is the eISSN & pISSN for Biotechnology Letters?
For Biotechnology Letters, eISSN is 1573-6776 and pISSN is 0141-5492.
What is Citescore for Biotechnology Letters?
Citescore for Biotechnology Letters is 4.
What is the SJR for Biotechnology Letters?
SJR for Biotechnology Letters is Q3.
Who is the publisher of Biotechnology Letters?
Springer Nature is the publisher of Biotechnology Letters.